| Human cellular microRNA hsa-miR-29a interferes with viral nef protein expression and HIV-1 replication JK Ahluwalia, SZ Khan, K Soni, P Rawat, A Gupta, M Hariharan, V Scaria, ... Retrovirology 5, 1-10, 2008 | 336 | 2008 |
| Measuring glutathione redox potential of HIV-1-infected macrophages A Bhaskar, MH Munshi, SZ Khan, S Fatima, R Arya, S Jameel, A Singh Journal of Biological Chemistry 290 (2), 1020-1038, 2015 | 62 | 2015 |
| Reciprocal regulation of human immunodeficiency virus-1 gene expression and replication by heat shock proteins 40 and 70 M Kumar, P Rawat, SZ Khan, N Dhamija, P Chaudhary, DS Ravi, D Mitra Journal of molecular biology 410 (5), 944-958, 2011 | 49 | 2011 |
| Testing Preexisting Antibodies Prior to AAV Gene Transfer Therapy: Rationale, Lessons and Future Considerations LRRK Jerry R. Mendell, Anne M. Connolly, Kelly J. Lehman, Danielle A ... Molecular Therapy - Methods & Clinical Development, 2022 | 43 | 2022 |
| HSP70 binding protein 1 (HspBP1) suppresses HIV-1 replication by inhibiting NF-κB mediated activation of viral gene expression P Chaudhary, SZ Khan, P Rawat, T Augustine, DA Raynes, V Guerriero, ... Nucleic acids research 44 (4), 1613-1629, 2016 | 41 | 2016 |
| Apoptosis-induced activation of HIV-1 in latently infected cell lines SZ Khan, N Hand, SL Zeichner Retrovirology 12, 1-19, 2015 | 39 | 2015 |
| Targeting IκB proteins for HIV latency activation: The role of individual IκB and NF-κB proteins. Guerau Fernandez, Thomas D. Zaikos, Sohrab Z. Khan Journal of Virology, 2013 | 36 | 2013 |
| Cyclin K inhibits HIV-1 gene expression and replication by interfering with cyclin-dependent kinase 9 (CDK9)-cyclin T1 interaction in Nef-dependent manner SZ Khan, D Mitra Journal of Biological Chemistry 286 (26), 22943-22954, 2011 | 20 | 2011 |
| Risk for HIV-1 infection is not associated with repeat-region polymorphism in the DC-SIGN neck domain and novel genetic DC-SIGN variants among North Indians A Rathore, A Chatterjee, V Sood, SZ Khan, AC Banerjea, N Yamamoto, ... Clinica Chimica Acta 391 (1-2), 1-5, 2008 | 15 | 2008 |
| Nuclear transit and HIV LTR binding of NF-κB subunits held by IκB proteins: implications for HIV-1 activation SZ Khan, S Gasperino, SL Zeichner Viruses 11 (12), 1162, 2019 | 7 | 2019 |
| Host genes that affect progression of AIDS/HIV in India and novel gene therapeutic approaches against HIV V Sood, A Rathore, S Husain, S Khan, S Patra, V Shankar, H Kumar, ... CSIR, 2008 | 3 | 2008 |
| AAV-based CRISPR-Cas9 genome editing: challenges and engineering opportunities AM Kabadi, MK Mejia-Guerra, JD Graef, SZ Khan, EM Walton, X Wang, ... Current Opinion in Biomedical Engineering, 100517, 2023 | 2 | 2023 |
| Cyclin K inhibits HIV-1 gene expression and replication by interfering with CDK9-cyclin T1 interaction in Nef dependent manner SZ Khan, D Mitra J. Biol. Chem 286, 22943-22954, 2011 | 2 | 2011 |
| T-cell response to micro-dystrophin in a patient treated with delandistrogene moxeparvovec gene therapy: a case of immune-mediated myositis (P. 54) S Khan, H Haegel, A Hollenstein, C Wandel, D Asher, DA Griffin, ... Paper Presented at: World Muscle Society (WMS), 2023 | 1 | 2023 |
| Adeno-associated virus antibodies and fragments thereof K Sohrab, D Griffin, L Rodino-Klapac US Patent App. 17/348,356, 2021 | 1 | 2021 |
| P17 Safety and efficacy of pre-treatment with imlifidase prior to AAV-based gene therapy in non-human primates with pre-existing anti-AAVrh74 antibodies R Potter, S Khan, J Snedeker, K Adegboye, A Haile, B Sayanjali, N Pukos, ... Neuromuscular Disorders 33, S101, 2023 | | 2023 |
| P54 T-cell response to SRP-9001 dystrophin transgene in a patient treated with Delandistrogene Moxeparvovec: a case of immune-mediated myositis S Khan, H Haegel, A Hollenstein, C Wandel, K Wagner, D Asher, D Griffin, ... Neuromuscular Disorders 33, S72, 2023 | | 2023 |
| EPH51 Algorithms for Identifying Immunocompromised Adults in Administrative Claims Data–a Targeted Literature Review N Stempniewicz, A Steffens, H Trenz, S Khan, R Ahlawat, S Poston, ... Value in Health 26 (6), S173, 2023 | | 2023 |
| HSD4 Opioid Use Among Migraine Patients Treated with Acute and Preventive Treatment H Trenz, S Khan, KP Singh, G Allenback, JT McPheeters, K Batra Value in Health 26 (6), S239, 2023 | | 2023 |
| HSD64 Biologics Vs. Biosimilars Utilization Among Rheumatoid Arthritis (RA) Patients K Batra, J Friderici, P Veeranki, JT McPheeters, KP Singh, S Khan Value in Health 26 (6), S249, 2023 | | 2023 |
Debashis MitraScientist, NCCS, Pune在 nccs.res.in 的电子邮件经过验证
